Welcome to Tacoma Vet Medications



Increlex (mecasermin) is a man-made form of insulin-like growth factor-1 (IGF-1), a substance that is normally produced in the body. IGF-1 is important for the growth of bones and muscles.


Introduction to Increlex: Unveiling a Growth Revolution:

Increlex (mecasermin) is a prescription medication that contains recombinant human insulin-like growth factor-1 (IGF-1). It is used for the treatment of a rare medical condition known as growth hormone insensitivity syndrome (GHIS), also referred to as insulin-like growth factor-1 deficiency (IGFD).

Generic Name: Mecasermin

Brand name: Increlex

GHIS is a genetic disorder characterized by a lack of response to growth hormone (GH), which leads to short stature and poor growth in affected individuals. Normally, GH is produced by the pituitary gland and stimulates the production of IGF-1 in the liver. IGF-1 plays a crucial role in promoting the growth and development of bones, muscles, and other tissues.

However, individuals with GHIS have a defect in the GH receptor or related signaling pathways, which results in reduced production of IGF-1 and impaired growth. Increlex, being a form of recombinant IGF-1, can help address this deficiency and promote linear growth in children with GHIS. 

Key points about Increlex:

Indication: Increlex is indicated for the long-term treatment of children with growth failure due to severe primary IGF-1 deficiency (GHIS/IGFD) or with GH gene deletion who have developed neutralizing antibodies to GH.

Administration: Increlex is administered by subcutaneous (under the skin) injection. It is usually given once or twice daily, depending on the specific treatment plan recommended by the healthcare provider.

Monitoring: Regular monitoring of growth and IGF-1 levels is essential to adjust the dose and ensure optimal treatment outcomes.

Adverse Effects: Like any medication, Increlex can have side effects. Common side effects may include injection site reactions, headaches, and low blood sugar (hypoglycemia). Your doctor will monitor for these and other potential side effects. 

Contraindications: Increlex should not be used in individuals with a known hypersensitivity to mecasermin or any of its components. 

Usage in Athletes: It’s important to note that IGF-1, including Increlex, has been abused by some athletes and bodybuilders for its potential to enhance muscle growth and performance. However, such use is not approved and can lead to serious health risks.

Tacoma Vet Medication: Your Trusted Online Source for Increlex

Tacoma Vet Medication, your premier destination for purchasing Increlex online. We understand the importance of reliable and convenient access to quality medications for your pet’s health needs. Whether you’re seeking Increlex to address growth hormone deficiencies or other veterinary requirements, we’re here to ensure a seamless and secure shopping experience.

Why Choose Tacoma Vet Medication for Increlex?

Trusted Expertise: With years of experience in the veterinary pharmaceutical industry, we are your knowledgeable partner in animal health.

Authenticity Guaranteed: Our Increlex products are sourced directly from reputable manufacturers, ensuring authenticity and effectiveness.

Convenience at Your Fingertips: Our user-friendly online platform allows you to buy Increlex from the comfort of your home, eliminating the hassle of traditional pharmacy visits.

Increlex for sale today from Tacoma Vet Medication: 

Elevate your pet’s well-being with Increlex from Tacoma Vet Medication. Browse our selection, place your order, and rest assured that you’re providing the best care for your furry companion’s health and growth needs.

Please note that Increlex is a prescription medication, and you should consult a qualified veterinarian before administering it to your pet. Tacoma Vet Medication encourages responsible and informed pet healthcare decisions.


There are no reviews yet.

Be the first to review “increlex”

Your email address will not be published. Required fields are marked *

You cannot copy content of this page